FDA Approves Cantharidin for Treating Molluscum Contagiosum FDA Approves Cantharidin for Treating Molluscum Contagiosum

The product is a drug-device combination that contains a formulation of cantharidin solution (0.7%), delivered topically via a single-use applicator.MDedge News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news